Satellite Banner
Scientific Community
Become a Member | Sign in
Home>News>This Article

Cancer Researcher Wins Cytation™ 3 in BioTek's Contest!

Published: Saturday, April 12, 2014
Last Updated: Friday, April 11, 2014
Bookmark and Share
Dr. Jeff Peterson wins Cytation™ 3 cell imaging multi-mode reader in "Think Possible" Application Contest.

BioTek congratulates Dr. Jeff Peterson of the Fox Chase Cancer Center in Pennsylvania for winning a new Cytation™ 3 Cell Imaging Multi-Mode Reader in BioTek's "Think Possible" Application Contest.

Entrants were judged on a short essay that they submitted, detailing the application that they think is possible for their specific research using the Cytation 3. As an Associate Professor, Dr. Peterson studies chemical biology and kinase signaling in cancer.

"Multiplexing of disparate assays using multiple detection modalities is the future," Dr. Peterson wrote as part of his essay. "Cytation 3 is the first instrument that I am aware of that bridges the gap between imaging-based phenotypic screening and targeted assays using biochemical readouts. When both approaches are feasible simultaneously, the debate between phenotypic and targeted screening approaches dissolves to reveal a new world of possibilities."

As Dr. Peterson noted in his essay, patent pending Cytation 3 provides both quantitative and phenotypic cellular analyses by combining automated digital fluorescence microscopy and conventional microplate detection in a single platform.

Multi-channel widefield fluorescence and brightfield imaging are supported using high-intensity LED light sources and onboard filter cubes, and automated functions allow increased throughput compared to manual microscopy systems.

Hybrid Technology™ multi-mode detection combines high sensitivity filter-based detection and flexible monochromator-based detection for unmatched assay versatility now and in the future. This modular, parallel data acquisition platform allows scientists to collect more meaningful data, increase sample throughput, and reduce experimental time.

Cytation 3 is the recipient of three awards since its launch: the MipTec New Product Innovation Award, the SelectScience "Scientists' Choice Award for Best Drug Discovery Product" Award, and Thermo Fisher Scientific "Extraordinary New Product Line Award". It is also a finalist in the 2014 Edison Awards® competition.

Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,200+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

DLReady Certification Awarded for Synergy 2 and Synergy HT Multi-Detection Microplate Readers
Awarded by Promega Corporation, this certification validates an instrument to the highest performance levels and standards for the Dual-Luciferase® Reporter Assay System.
Monday, November 06, 2006
Scientific News
Unravelling the Role of Key Genes and DNA Methylation in Blood Cell Malignancies
Researchers from the University of Nebraska Medical Center have demonstrated the role of Dnmt3a in safeguarding normal haematopoiesis.
Lab-on-a-Chip to Help Detect Cancer
In this podcast, we speak to Gustavo Stolovitsky to learn about his career and the work he is doing at IBM Research.
Driving Mosquito Evolution to Fight Malaria
Researchers propose insect repellent in conjunction with insecticides to extend current insecticide lifetime.
Tumor Markers Reveal Lethality Of Bladder Cancers
Researchers found that detection of certain tumor cells in early stage cancers helps identify high-risk cancers.
Gene Editing Corrects Sickle Cell Mutation
Researchers demonstrate a potential pathway to developing gene-editing treatments for sickle cell disease.
ALS Study Reveals Role of RNA-Binding Proteins
The findings are a significant step forward in validating RNA-based therapy as a treatment for ALS.
Observing Direct Inheritance of Gene-Silencing RNA
Research has allowed for the observation of double-stranded RNA molecule being passed from parent to offspring in roundworms.
New Compound Shows Promise in Treating Multiple Human Cancers
The research presents a new way to efficiently kill these cancerous cells and holds promise for the treatment of all cancers.
Using CRISPR to Accelerate Search for HIV Cure
Gene-editing platform makes it easier to create HIV-resistant immune cells.
IU Research Reveals Link between Molecular Mechanisms in Prostate Cancer and Ewing's sarcoma
Researchers at IU have suggested that the molecular mechanism that triggers the rare disease Ewing's sarcoma could act as a potential new direction for the treatment of more than half of patients with prostate cancer.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,200+ scientific videos